Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
MORGAN STANLEY
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 639,756 | -159,040 | 16,192,226,000 | 1,446,453,000 | $25,310.00 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | 798,796 | 116,091 | 14,745,773,000 | 14,727,341,000 | $18,460.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 682,705 | 179,621 | 18,432,000 | 11,479,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 503,084 | 85,977 | 6,953,000 | -1,180,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 417,107 | 48,020 | 8,133,000 | 2,110,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 369,087 | 86,477 | 6,023,000 | -1,850,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 282,610 | -8,114 | 7,873,000 | -744,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 290,724 | 122,144 | 8,617,000 | 3,906,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 168,580 | 16,616 | 4,711,000 | 403,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 151,964 | 63,121 | 4,308,000 | 2,074,000 | $28.35 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 88,843 | -10,371 | 2,234,000 | -188,000 | $25.15 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 99,214 | 67,557 | 2,422,000 | 1,954,000 | $24.41 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 31,657 | -58,231 | 468,000 | -991,000 | $14.78 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 89,888 | 62,049 | 1,459,000 | 1,097,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 27,839 | 21,771 | 362,000 | 283,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 6,068 | -102,148 | 79,000 | -1,627,000 | $13.02 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 108,216 | -45,030 | 1,706,000 | -1,378,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 153,246 | -294 | 3,084,000 | -731,000 | $20.12 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 153,540 | -29,219 | 3,815,000 | -1,202,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 182,759 | 12,358 | 5,017,000 | -231,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 170,401 | -57,607 | 5,248,000 | -2,903,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 228,008 | 101,236 | 8,151,000 | 4,658,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 126,772 | -26,898 | 3,493,000 | 3,489,803 | $27.55 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 153,670 | -27,626 | 3,197 | -3,749,803 | $0.02 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 181,296 | 65,031 | 3,753,000 | 1,869,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 116,265 | 116,265 | 1,884,000 | 1,884,000 | $16.20 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 90,037 | 90,037 | 1,225,000 | 1,225,000 | $13.61 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 75,196 | 75,196 | 1,312,000 | 1,312,000 | $17.45 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 20,799 | 20,799 | 711,000 | 711,000 | $34.18 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 3,560 | 3,560 | 106,000 | 106,000 | $29.78 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 59,420 | 59,420 | 1,900,000 | 1,900,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 7,047 | 7,047 | 146,000 | 146,000 | $20.72 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 6,541 | 6,541 | 111,000 | 111,000 | $16.97 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 5,906 | 5,906 | 115,000 | 115,000 | $19.47 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 4,513 | 4,513 | 154,000 | 154,000 | $34.12 |
| << Prev Next >> |
|